-+ 0.00%
-+ 0.00%
-+ 0.00%

Context Therapeutics Announces Phase 1 Clinical Trial of CT-95 Bispecific T Cell Engager for Advanced Solid Tumors at SITC 2025

Reuters·10/06/2025 11:30:58

Please log in to view news